Clinical Trial: A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease

U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07450144) titled 'A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease' on Feb. 26.

Brief Summary: The goal of this pilot randomized controlled trial is to evaluate the trial feasibility and acceptability of LLM-based chatbot for reducing alcohol use among patients with metabolic alcohol-related liver disease. Specific objectives include:

1. To assess how many MetALD patients accept the invitation to participate in the trial

2. To assess the retention rate of the participants through 3 and 6 months after treatment initiation

3. To assess the acceptability of the LLM-based chatbot in te...